尼莫地平在蛛网膜下腔出血中的应用

Application of Nimodipine in Subarachnoid Hemorrhage

目的:探讨在蛛网膜下腔出血(SAH)中应用选择性钙离子拮抗剂尼莫地平减少因脑动脉痉挛而导致的再出血、缺血性脑卒中的发生率。方法:对23例蛛网膜下腔出血患者应用尼莫地平静点1～3周后改口服6～8周。结果:23例患者经住院治疗后全部痊愈出院无后遗症。结论:应用尼莫地平对蛛网膜下腔出血后脑动脉痉挛继发脑缺血有明确的临床疗效。

Objective： To explore the subarachnoid hemorrhage （SAH） in the selective application of calcium antagonist nimodipine reduce cerebral artery spasm caused by the bleeding, ischemic stroke incidence. Methods： 23 cases of patients with subarachnoid hemorrhage nimodipine to calm point to 1 - 3 weeks after oral 6 - 8 weeks. Results： 23 cases of patients with hospital treatment after all recovered and discharged without sequelae. Conclusion： nimodipine on the brain artery spasm subaraehnoid hemorrhage secondary to cerebral ischemia have a clear clinical effect.